The authors identified polymorphisms predicting individual HCC susceptibility in high-risk HBV and HCV patients, such as ERCC1, GSTP1, CYP17A1, XRCC3 and ABCB1. These findings could contribute to HCC surveillance and early detection (181). This evidence concerns the gene ABCB1 and hepatocellular carcinoma.